Author:
Kolho Kaija-Leena,Alfthan Henrik,Hämäläinen Esa
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Pediatrics, Perinatology, and Child Health
Reference11 articles.
1. Assessment of the disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein.;Roseth;Digestion,1997
2. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.;Bunn;J Pediatr Gastroenterol Nutr,2001
3. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.;Kolho;Scand J Gastroenterol,2006
4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.;Langhorst;Am J Gastroenterol,2008
5. Crohns disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohns disease activity index and endoscopic findings.;Sipponen;Inflamm Bowel Dis,2008
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fecal calprotectin as a marker of inflammatory bowel diseases;Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics);2023-11-16
2. Biological markers of disease activity in inflammatory bowel diseases;Gastroenterology Review;2023
3. Fecal Markers in Inflammatory Bowel Disease;Pediatric Inflammatory Bowel Disease;2023
4. La calprotectina fecal;FMC - Formación Médica Continuada en Atención Primaria;2022-12
5. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease;Diagnostics;2021-12-27